Shares of French biotech company Abivax soared Tuesday after it released fresh data on its lead drug for bowel disease.
Source: [CNBC](https://www.cnbc.com/2026/06/30/abivax-stock-trial-data-biotech-obefazimod.html)
📰 Read Full Story
This is an aggregated headline summary. For the complete report, visit the original publisher.
Continue Reading at CNBC ↗